Table 1.
Genotype/haplotype
|
No. non-HIV-1-infected (frequency, %)
|
No. HIV-1-infected (frequency, %)
|
||||||
---|---|---|---|---|---|---|---|---|
−403 | −28 | Total | Hemophiliacs | Nonhemophiliacs | Total | Hemophiliacs | Nonhemophiliacs | |
Genotype | ||||||||
1 | G/G | C/C | 79 (40.9) | 16 (32.0) | 63 (44.0) | 117 (43.0) | 64 (44.4) | 53 (41.4) |
2 | A/A | C/C | 9 (4.7) | 3 (6.0) | 6 (4.2) | 13 (4.8) | 6 (4.2) | 7 (5.5) |
3 | A/A | G/G | 8 (4.1) | 1 (2.0) | 7 (4.9) | 11 (4.0) | 3 (2.1) | 8 (6.2) |
4 | G/A | C/C | 49 (25.4) | 18 (36.0) | 31 (21.7) | 69 (25.4) | 40 (27.8) | 29 (22.7) |
5 | G/A | C/G | 34 (17.6) | 7 (14.0) | 27 (18.9) | 48 (17.6) | 26 (18.1) | 22 (17.2) |
6 | A/A | C/G | 14 (7.3) | 5 (10.0) | 9 (6.3) | 14 (5.2) | 5 (3.5) | 9 (7.0) |
Total | 193 (100) | 50 (100) | 143 (100) | 272 (100) | 144 (100) | 128 (100) | ||
Haplotype | ||||||||
I | G | C | 241 (62.4) | 57 (57.0) | 184 (64.3) | 351 (64.5) | 194 (67.4) | 157 (61.3) |
II | A | C | 81 (21.0) | 29 (29.0) | 52 (18.2) | 109 (20.0) | 57 (19.8) | 52 (20.3) |
III | A | G | 64 (16.6) | 14 (14.0) | 50 (17.5) | 84 (15.5) | 37 (12.8) | 47 (18.4) |
Total | 386 (100) | 100 (100) | 286 (100) | 544 (100) | 288 (100) | 256 (100) |